July 12 (Reuters) - Cipher Pharmaceuticals Inc CPH.TO
* Cipher Pharmaceuticals announces ozenoxacin accepted for
review by Health Canada
* Cipher Pharmaceuticals Inc says that its new drug
submission for ozenoxacin has been accepted for review by Health
Canada
Source text for Eikon: ID:nPn8DjL6ja
Further company coverage: CPH.TO